Sun, Apr 20, 2014, 12:52 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Peregrine Pharmaceuticals, Inc. Message Board

  • insideinvestor00 insideinvestor00 Nov 30, 2012 11:10 AM Flag

    Why its Moving Up Again...Insiders know that Buyout proposal soon from Novartis and Positive Data Released Soon!!?!!

    The data from the previous trail can still be used and will reflect positive results...Again!! Plus there will be positive news released soon for the other studies the company is currently processing. For traders in the drug world keep in mind that Novartis wants to add a cancer drug to its portfolio and have shown interest in PPHM in the past. It currently has an interest in Cell Therapeutics but as of now has not exercised the right (see CTIC history) as they are wanting a US FDA approved drug and that is something CTIC cannot provide. Navortis has shown interest in Peregine Pharmaceuticals before, but were pushed away as ownership wanted to go solo. However, with that has recently happened Novartis has contacted PPHM again with hopes of coming to an agreement. For those that don't know, Novartis is a very large and cash positive pharmaceutical company based in Europe. I'm sure that PPHM ownership is listening to Novartis this time since Novartis has many times over had approved drugs and has ownership in many companies including Alcon (ACL) and knows what it takes to help companies corrrect clinical trail issues and ultamately achieve FDA approval. The data from the previous trail can still be used and will reflect positive results...Again!! Plus there will positive news released soon for the other studies the company currently processing.

    Sentiment: Strong Buy

 
PPHM
1.73+0.04(+2.37%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.